Pricing Log in Create free account

Cellectis S.A. (CLLS) vs Tenaya Therapeutics, Inc. (TNYA)

Cellectis S.A. and Tenaya Therapeutics, Inc. are both Biotechnology companies. Cellectis S.A. and Tenaya Therapeutics, Inc. are of similar size ($84.6M and $84.3M). Tenaya Therapeutics, Inc. has the higher net margin (0.00% vs −102.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Tenaya Therapeutics, Inc. leads on 8 and Cellectis S.A. on 5.

Valuation

Metric CLLS TNYA Biotechnology median
P/E n/m n/m 10.26
P/S 1.59 n/m 9.18
P/B 2.48 1.29 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 0.13 n/m 8.98
Earnings yield (64.76%) (158.06%) (34.89%)
Free cash flow yield (45.45%) (78.04%) (24.52%)

Profitability

Metric CLLS TNYA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (90.88%) 0.00% 0.00%
Net margin (102.34%) 0.00% 0.00%
Free cash flow margin (68.63%) 0.00% 0.00%
Return on equity (94.54%) (148.16%) (50.12%)
Return on assets (21.02%) (112.05%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLLS TNYA Biotechnology median
Revenue growth (TTM) 0.61% — 6.26%
EPS growth (last fiscal year) (63.41%) 54.96% 29.88%
Revenue growth, 5-year CAGR (0.70%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLLS TNYA Biotechnology median
Debt to equity 1.79 0.00 0.00
Current ratio 1.37 3.78 4.89
Net debt to EBITDA 9.54 1.19 1.01

Dividend

Metric CLLS TNYA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLLS TNYA Biotechnology median
Market cap 84.63m 84.31m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack